Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma - Wikidata - wikimedia - TriplyDB

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

http://www.wikidata.org/entity/Q28270332

about

Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study Peripheral T-cell lymphoma: review and updates of current management strategies Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Controversies in the treatment of lymphoma with autologous transplantation.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Transplantation for non-Hodgkin lymphoma.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Treatment algorithms for mature T-cell and natural killer-cell neoplasms.Hematopoietic cell transplantation for lymphomas.Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.Autologous hematopoietic cell transplantation: an update for clinicians.Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.Investigational drugs for T-cell lymphoma.How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.Autologous stem cell transplantation for aggressive lymphomas.

P2860

Q26998446-D6B5587D-159E-42B1-BCAB-E12D2278B9F4 Q30613674-EA0544DD-9E7C-4BB4-99DF-3A0B558FB0A2 Q33396356-9770D3AF-3632-4084-B434-CFCFEC5678C2 Q33434137-63B6FD42-E222-4E21-803B-8B8CBC07023D Q33608520-1AA1A8CF-EA32-4A19-886F-83C167E4B8D9 Q33822764-BBA5C471-64FD-4383-B139-2B7EF6759C6F Q34226010-626E28C8-3906-4223-B608-C3E095803607 Q34479082-8A4A944D-3BD4-489E-A083-04745D3E336F Q35025993-630F0A0E-69F1-4BFB-B950-6B27A55F71E9 Q35163220-149BC254-C28B-44E3-9C65-7402620CADC2 Q35224833-2C252F66-0D7A-40C1-B03F-BC6C5ECD317C Q35232775-ED99B6E3-8F1F-425D-93ED-542738E8341B Q35533531-36D4DBC0-F574-4A1C-B71C-E24F74F9144B Q35703714-0E6FCDA1-FA1E-44F1-A043-B61C72145A29 Q36283958-D20F5E55-D900-4C73-B6DC-C47F3211C6A6 Q36355093-C3E9B3CE-7F0E-4A04-9E40-08BCEED83D5B Q36360736-F99DE757-4BE5-4230-8395-8143A2CF1C2E Q36604739-A820DBC6-F281-464D-A622-E133C215C4F4 Q36907048-AEB53F7A-8DBF-415E-A188-BD487E76F01F Q37122302-BC98D628-3278-49DC-9724-237DCFEDD80E Q37271019-16ED61AE-DFD9-4D10-B2C4-EDC4C365CCF1 Q37391571-AF74C789-083F-46D5-B634-229A9ED71ED2 Q37593800-E04964D1-6993-4378-B94B-3B1E7B76822A Q37809085-DAF300A4-AD5E-4203-A226-BD33A017F486 Q37810079-5F7CCCC4-F16D-46AA-B8A9-6981A4C66ADB Q37863688-6ED2B0DC-1D6D-4A93-B0E1-629406523C7A Q37932546-B19BABF5-6E94-4029-9FD2-220CD7DFF810 Q37942817-8D40593D-EE8C-41CC-8D02-8AB106F20BA6 Q38046051-0A414226-3D63-4AE1-A8FC-A4CA73BA50BE Q38113568-EF139B4B-74FA-43F6-86F2-EF02D510367E Q38132821-0A9086AE-4CA5-4307-A4BA-E9AA1FF85258 Q38198754-8FD4F970-212B-44CD-844E-8BBD1EBEA7D4 Q38209433-ED52E6A2-EAB5-45ED-9217-44E2F34BE7BB Q38248359-41E4EC31-C444-43A1-9A3A-BAD87BEDADAF Q38528166-C6293F99-A280-4A4F-B594-1EA5E9F5E20A Q38635909-1B475B31-7C8C-445D-92FF-A01DAA5508F4 Q38782072-AD579B0B-DAF1-4CF5-93A5-E7190776CDC3 Q38949798-E9306809-6E69-4B25-9326-C5A4C84D4F63 Q41928592-882A602E-BAB9-43A5-B4F9-1BABC2C1E79C Q42357660-F9C244A3-36E9-427E-8C19-34913F5602F0

P2860

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

http://www.wikidata.org/entity/Q28270332

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@ast

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@en

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@nl

type

label

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@ast

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@en

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@nl

prefLabel

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@ast

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@en

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@nl

P1433

Q28270332-C17A6B57-C276-47DB-BA7C-C9D1CD6EF7EC

P1476

Q28270332-7092E3ED-AC6B-4F17-B8CA-010CFA29E194

P2093

Q28270332-02027972-660B-43AD-B934-E2268C09F465

Q28270332-2ECE85B3-A082-4DF6-9F8F-87AA0D2E322B

Q28270332-3BAE77B8-A31C-4D7C-B4B3-81D0DB654CC2

Q28270332-3EE0D9B5-2CA0-41FA-9BBF-C146CFA9C582

Q28270332-550734DF-618B-4C10-A6EE-94EF1D008EA2

Q28270332-9F419CDD-54B0-49A4-887D-D5F9575C487A

Q28270332-C1A15E54-EB5F-4521-95F1-3F8BC9098482

Q28270332-D97EC9A4-A539-48BD-AD7F-6430BDE58FB7

Q28270332-F2622670-BC4D-4835-8435-2C76E3655105

P304

Q28270332-043D146F-D25A-46CA-BD6D-44D7504C305A

P31

Q28270332-C89A80B8-5D21-4F73-ACD7-CCE3FA5257E3

P3181

Q28270332-F2E2BF86-3B3D-48FB-ACF3-1A020CFC279F

P356

Q28270332-8756678F-3AD3-4A04-8884-14C10DC664A5

P407

Q28270332-C3771154-4B84-46C6-BA30-FC8A21E35C9B

P433

Q28270332-217A56DB-CE08-40D0-9CE1-21045EC1BF4C

P478

Q28270332-AD96320E-763E-47D3-A03E-9B3FFD7231F1

P50

Q28270332-2BC4C5F2-E290-4420-9F35-1197C048A159

Q28270332-334E67B9-7793-4A8B-B87B-D6C13571D8CA

Q28270332-7B65CFEC-9A42-4F79-9C54-F7E826CF48F5

Q28270332-926595C4-818D-4EA7-9393-D4FB5857FD6C

Q28270332-9CCF3DFC-0D80-4892-A06B-CB82198B604F

Q28270332-BD262F6C-76C4-46D9-B68B-2A22A87623FA

Q28270332-E7D04245-470E-4381-AF77-D3E6BE560151

P577

Q28270332-3018E735-B8BB-4B8A-9D4F-08D952F68467

P5875

Q28270332-81811410-144E-4DF2-88CB-64B8B8C355C0

P698

Q28270332-D0A7246E-83FD-4C4D-AC8C-9F6B0D872E12

P921

Q28270332-8D3E0267-DFFF-4C1E-81A4-D782ABD04621

P3181

P356

P1433

Annals of Oncology

P1476

Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma

@en

P2093

A López-Guillermo

http://www.w3.org/2001/XMLSchema#string

C Estany

http://www.w3.org/2001/XMLSchema#string

C Pedro

http://www.w3.org/2001/XMLSchema#string

E Montserrat

http://www.w3.org/2001/XMLSchema#string

Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)

http://www.w3.org/2001/XMLSchema#string

I Espinosa

http://www.w3.org/2001/XMLSchema#string

L Escoda

http://www.w3.org/2001/XMLSchema#string

R Martino

http://www.w3.org/2001/XMLSchema#string

S Mercadal

http://www.w3.org/2001/XMLSchema#string

P304

958-963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4244538

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/ANNONC/MDN022

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Salome Martinez

Gonzalo Gutiérrez-García

Josep-Maria Ribera

P577

2008-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5549488

http://www.w3.org/2001/XMLSchema#string

P698

18303032

http://www.w3.org/2001/XMLSchema#string

P921